Portal Hypertension and Its Complications

Slides:



Advertisements
Similar presentations
CIRRHOSIS. Use of nonspecific has been studied extensively in randomized, controlled trials of the primary prophylaxis of variceal bleeding. β-adrenergic.
Advertisements

Creatinine (mg/dL) MonthsWeeks Therapeutic paracentesis Cefotaxime Type-2 HRSType-1 HRS Encephalopathy Jaundice CLINICAL TYPES.
Complications of liver cirrhosis
Volume 350: April 15, 2004 Number 16 Management of Cirrhosis and Ascites Pere Ginès, M.D., Andrés Cárdenas, M.D., Vicente Arroyo, M.D., and Juan.
Definition  Is a chronic disease characterized by scaring and necrotic tissue replaced by fibrotic tissue. Resulting in hepatic insufficiency and portal.
Complications of liver cirrhosis. Recognize the major complications of cirrhosis. Understand the pathological mechanisms underlying the occurrence of.
The Kidney in Liver Disease
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Volume 135, Issue 5, Pages (November 2008)
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
Thrombocytopenia With Abnormal Liver Function Tests
Volume 136, Issue 5, Pages (May 2009)
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Acute Kidney Injury in Patients With Cirrhosis: Perils and Promise
Volume 152, Issue 4, Pages (March 2017)
Vasoconstrictor Therapy for the Hepatorenal Syndrome
Christoph Lübbert, Babett Holler  Gastroenterology 
Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis  Guadalupe.
Evaluation and Management of End-Stage Liver Disease in Children
Treatment of Hyperammonemia in Liver Failure: A Tale of Two Enzymes
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis  Lorenzo Loffredo, Daniele Pastori,
Genetics and Genomics in the Practice of Medicine
Volume 139, Issue 4, Pages e1 (October 2010)
Outcomes Among Living Liver Donors
Volume 134, Issue 5, Pages (May 2008)
Roberts Brown, Jean C. Emond  Gastroenterology 
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Mechanisms of Hepatic Fibrogenesis
Kidney Disease in the Setting of Liver Failure: Core Curriculum 2013
Volume 130, Issue 4, Pages (April 2006)
Human serum albumin, systemic inflammation, and cirrhosis
Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death  Andrea Ribeiro de Souza, Vincenzo.
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Khursheed N. Jeejeebhoy  Gastroenterology 
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis  Lorenzo Loffredo, Daniele Pastori,
Pulmonary Arterial Hypertension Associated With the Chinese Herb Indigo Naturalis for Ulcerative Colitis: It May Be Reversible  Mayu Nishio, Keiji Hirooka,
Acute-on chronic liver failure
Vicente Arroyo, Carlos Terra, Pere Ginès  Journal of Hepatology 
Volume 145, Issue 4, Pages (October 2013)
Acute-on-Chronic Liver Failure, Human Serum Albumin, and Immune Modulation: The Beginning of an Exciting Adventure  Vicente Arroyo  Clinical Gastroenterology.
Colon Cancer: An Update and Future Directions
Volume 136, Issue 5, Pages (May 2009)
Volume 148, Issue 5, Pages (May 2015)
The heart in liver transplantation
Clinical states of cirrhosis and competing risks
Colin Crooks, Tim Card, Joe West  Gastroenterology 
Volume 137, Issue 1, Pages (July 2009)
Recurrent variceal bleeding despite endoscopic and medical therapy
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
AGA technical review on nonalcoholic fatty liver disease
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Amer A. Alkhatib, MD, Rodney W. Stuart, MD, Ronald L. Weiss, MD 
Esophageal variceal bleeding: Primary prophylaxis
Volume 156, Issue 1, Pages 7-10 (January 2019)
Thrombocytopenia With Abnormal Liver Function Tests
Douglas A. Simonetto, MD, Mengfei Liu, MD, Patrick S. Kamath, MD 
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Controversies in Liver Transplantation for Hepatitis C
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
M. Mazen Jamal, Jason B. Samarasena, Mehrtash Hashemzadeh, Kenneth J
Volume 135, Issue 5, Pages (November 2008)
Presentation transcript:

Portal Hypertension and Its Complications Arun J. Sanyal, Jaime Bosch, Andres Blei, Vincente Arroyo  Gastroenterology  Volume 134, Issue 6, Pages 1715-1728 (May 2008) DOI: 10.1053/j.gastro.2008.03.007 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Pathophysiology of variceal bleeding. Bleeding occurs when the tension exerted by the thin wall of the varices exceeds the rupture point. This is facilitated by the progressive increase in the size of the varices and decreased wall thickness (A). These factors are mathematically interrelated in Laplace's law (B) and explain why an increased HVPG, the endoscopic apearance of the varices, and the degree of liver failure are associated with increased risk of variceal bleeding (C). Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Pathophysiology of ascites and hepatorenal syndrome. The initial event is splanchnic arterial vasodilation, which causes effective hypovolemia. This is compensated for by an increased cardiac output (hyperdynamic circulation). However, as the disease progresses, splanchnic arterial vasodilation increases and cardiac output decreases, leading to deterioration of circulatory function and stimulation of the renin-angiotensin-aldosterone system, sympathetic nervous system, and antidiuretic hormone. When circulatory dysfunction is moderate, patients develop sodium retention. When it is severe, patients develop a profound impairment in free water excretion and dilutional hyponatremia. Finally, when it is extreme, patients present with HRS. Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Glutamine as a “Trojan horse.” In astrocytes, glutamine is transported into mitochondria via specific transporters, where under the action of glutaminase, ammonia is regenerated. Mitochondrial dysfunction occurs, with the generation of reactive oxygen species (ROS) and the mitochondrial permeability transition. Astroglial dysfunction leads to altered glial-neuronal communications, with abnormalities in neurotransmission (eg, glutamate, GABA) and the development of encephalopathy. Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 An algorithm for the primary prophylaxis of variceal hemorrhage. Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 An algorithm for the management of variceal hemorrhage. Initial treatment is with endoscopic and pharmacologic treatment. Continued bleeding or severe early rebleeding can be managed with TIPS. Those who respond to first-line treatment should receive band ligation and β-blockers. A transplant evaluation should be initiated based on the standard of care locally. Varices should be ligated to obliteration, and suitable patients should undergo transplantation when an organ is available. TIPS is used as a salvage treatment for recurrent bleeding. Liver transplantation remains the only treatment that corrects both the portal hypertension and the underlying liver disease and is the definitive treatment of choice in the long-term for appropriate candidates. Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Arun J. Sanyal Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Jaime Bosch Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Andres Blei Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions

Vincente Arroyo Gastroenterology 2008 134, 1715-1728DOI: (10.1053/j.gastro.2008.03.007) Copyright © 2008 AGA Institute Terms and Conditions